Xnara Biologics South Asia Private Limited, a active foreign private limited company, was established on 06 April 2022 in Hyderabad, Telangana, India. Engaging in wellness & healthcare centers within the travel and hospitality sector, it holds CIN: U15549TG2022FTC161294. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Chong Huat Tan (Director), Doddy Vijay Kumar (Additional Director). Past directors included Yudishter Hakumal Bhagnani. It is based at Purva Summit, A Block,2Nd Floor, Whitefield'S, Hitech City, Hyderabad, Hyderabad, Telangana, 500081.
U15549TG2022FTC161294
161294
06 April 2022
₹1.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Xnara Biologics South Asia Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chong Huat Tan | Director | 06 Apr 2022 | Current |
| Doddy Vijay Kumar | Additional Director | 31 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Xnara Biologics South Asia's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Xnara Biologics South Asia's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Xnara Biologics South Asia has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Xnara Biologics South Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xnara Biologics South Asia's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Doddy Vijay Kumar was appointed as a Additional Director was appointed as a Additional Director on 31 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
Chong Huat Tan was appointed as a Director was appointed as a Director on 06 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
The activity Xnara Biologics South Asia Private Limited was registered on 06 Apr 2022 with Roc Hyderabad & aged 3 years 7 months as per MCA records. was completed.
The CIN of Xnara Biologics South Asia Private Limited is U15549TG2022FTC161294.
Xnara Biologics South Asia Private Limited is headquartered at Purva Summit, A Block,2Nd Floor, Whitefield'S, Hitech City, Hyderabad, Hyderabad, Telangana, 500081.
Xnara Biologics South Asia Private Limited was incorporated on 06 April 2022.
The current directors of Xnara Biologics South Asia Private Limited are
The primary industry of Xnara Biologics South Asia Private Limited is Travel And Hospitality.
Xnara Biologics South Asia Private Limited is unlisted.
The authorized capital of Xnara Biologics South Asia Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX